Another potential explanation could be that in ccRCC tumors, it has been shown that key opioid receptors such as the μ-opioid receptor (MOR) are not highly expressed, which could decrease the difference in amplitude of the results [14]. This evidence concerns the gene OPRM1 and nonpapillary renal cell carcinoma.